Skip to main content

Schonfeld Strategic Advisors LLC

Position in OGN — Organon & Co.

CIK 1665241 NEW YORK, NY

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$314,624 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
11 quarters on record

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$6,770,000
PutShares
500,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $100,420,553 across 10 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in OGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,770,000 500,000
2026-03-31 $314,624 52,525
2025-12-31 $214,999 29,986
2025-09-30 $4,753,208 445,057
2025-06-30 $4,693,425 484,858
2024-12-31 $949,941 63,669
2024-09-30 $412,557 21,566
2023-09-30 $1,043,735 60,123
2022-12-31 $601,472 21,535
2022-09-30 $208,260 8,900
2021-12-31 $1,990,577 65,372